Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2006

01-11-2006 | Case Report

Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature

Authors: Simone Appenzeller, Tiago Nardi Amaral, Eliane Maria Ingrid Amstalden, Manoel Barros Bertolo, João Francisco Marques Neto, Adil Muhib Samara, Sandra Regina M. Fernandes

Published in: Clinical Rheumatology | Issue 6/2006

Login to get access

Abstract

Septic arthritis demands early diagnosis and correct treatment if the function of the joint is to be restored. Sometimes, as in fungal infection, signs and symptoms may be mild and the diagnosis delayed. Nevertheless, the outcome of fungal arthritis is severe and usually causes joint disability. The authors report two patients with chronic monoarthritis due to Sporothrix schenckii infection diagnosed by synovial fluid cultures. Their clinical presentation, laboratory and image findings, and their treatment and follow-up are analyzed and compared to previously reported cases. These cases illustrate the differential diagnosis of monoarthritis in immunocompetent adults and picture clinical features that could lead to early diagnosis and proper treatment.
Literature
1.
Cuellar ML, Silveira LH, Citera GE, Cabrera GE, Valle R (1993) Other fungal arthritides. Rheum Dis Clin North Am 19:439–455PubMed
2.
Yacobucci GN, Santilli MD (1986) Sporotrichosis of the knee. A case report. Orthopedics 9:387–390PubMed
3.
Kauffman CA, Hajjeh R, Chapman SW (2000) Practice Guidelines for the Management of Patients with Sporotrichosis. For the Mycosis Study Group Infections Diseases Society of America. Clin Infect Dis Relat Res 30:684–687CrossRef
4.
Howell SJ, Toohey JS (1998) Sporotrichal arthritis in south central Kansas. Clin Orthop 346:207–214PubMed
5.
Mercurio MG, Elewski BE (1993) Therapy of sporotrichosis. Semin Dermatol 12:285–289PubMed
6.
Heller HM, Fuhrer J (1991) Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 5:1243–1246PubMed
7.
Sandhu K, Gupta S (2003) Potassium iodide remains the most effective therapy for cutaneous sporotrichosis. J Dermatolog Treat 14:200–202CrossRefPubMed
8.
Ozcan A, Senol M, Karaca S, Sener S, Polat M, Ozerol IH (2003) A case of sporotrichosis treated with itraconazole. Med Mycol 41:443–445CrossRefPubMed
9.
Hampton DE, Adesina A, Chodosh J (2002) Conjunctival sporotrichosis in the absence of antecedent trauma. Cornea 21:831–833CrossRefPubMed
10.
Ghosh A, Chakrabarti A, Hemashettar BM, Maiti PK (2001) In vitro susceptibility pattern of Sporothrix schenckii strains isolated from three centers in India. Indian J Med Res 113:214–220PubMed
11.
McGinnis MR, Nordoff N, Li RK, Pasarell L, Warnock DW (2001) Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B. Med Mycol 39:369–371PubMed
12.
De Rosso JQ, Gupta AK (1999) Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view. Postgrad Med 7:46–52
13.
Wescott BL, Nasser A, Jarolim DR (1999) Sporothrix meningitis. Nurse Pract 24:90, 93–94, 97–98PubMed
14.
Winn RE, Anderson J, Piper J, Aronson NE, Pluss J (1993) Systemic sporotrichosis treated with itraconazole. Clin Infect Dis 17:210–217PubMed
Metadata
Title
Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature
Authors
Simone Appenzeller
Tiago Nardi Amaral
Eliane Maria Ingrid Amstalden
Manoel Barros Bertolo
João Francisco Marques Neto
Adil Muhib Samara
Sandra Regina M. Fernandes
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0095-z

Other articles of this Issue 6/2006

Clinical Rheumatology 6/2006 Go to the issue

Original Article

Improvement of lung function in patients with systemic sclerosis after 6 months cyclophosphamide pulse therapy

Case Report

Successful treatment of a patient with primary Sjögren's syndrome with Rituximab

Case Report

Isolated pulmonary hypertension secondary to rheumatoid arthritis

Brief Report

Effectiveness of anakinra in rheumatic disease in patients naive to biological drugs or previously on TNF blocking drugs: an observational study

Original Article

The usefulness of power Doppler ultrasonography in differentiating primary and secondary Raynaud’s phenomenon

Original Article

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits